Non-invasive Prediction of EArly Cardiac rEjection
for Heart Transplant
Sites in Palo Alto, Los Angeles +20 more locations
Sponsor: Vanderbilt University Medical Center
Sex: All·Age: 6 - 25
Code: NCT07770659·Recruiting·Listed Aug 18, 2026
Paid Clinical Trials in Palo Alto, CA
As of September 2026, 654 paid clinical trials are recruiting in Palo Alto, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Palo Alto offers studies at sites including Stanford University for conditions such as Breast Cancer, Chronic Lymphocytic Leukemia, Epilepsy, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Palo Alto
Trials by drug in Palo Alto
Filter results
Filter results
Newly added in Palo Alto
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
for Heart Failure With Preserved Ejection Fraction (HFpEF)
Sites in Palo Alto, Mather +105 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07761117·Phase 3·Recruiting·Listed Aug 12, 2026
Human-Created vs AI-generated Art on Immediate Psychological Responses
for Psychological Well-Being
Sites in Palo Alto & Stanford
Sponsor: Stanford University
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07740148·Recruiting·Listed Jul 2026
540 clinical trials
Get a weekly email when new trials open in Palo Alto, CA.
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for Pneumococcal Disease
Sites in Palo Alto, Fresno +104 more locations
Sponsor: Pfizer
Sex: All·Age: 42 Days - 211 Days·Accepts healthy volunteers
Code: NCT07629440·Phase 3·Recruiting·Listed Jun 2026
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for Cognitive Dysfunction
Drug: Donanemab
Sites in Palo Alto, Irvine +40 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 55 - 85
Code: NCT07589595·Phase 2·Recruiting·Listed May 2026
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Palo Alto, San Francisco +99 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for Parkinson Disease
Sites in Palo Alto, Los Angeles +28 more locations
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All·Age: 30 - 80
Code: NCT07432958·Phase 2·Recruiting·Listed Feb 2026
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for Adenovirus Infections
Sites in Palo Alto, Sacramento +30 more locations
Sponsor: SymBio Pharmaceuticals
Sex: All·Age: 2 Months+
Code: NCT07387367·Phase 3·Recruiting·Listed Feb 2026
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for Intestinal Neoplasms
Drug: PF-08634404
Sites in Palo Alto, Sunnyvale +198 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for Pancreatic Cancer
Drug: daraxonrasib
Sites in Palo Alto, San Francisco +41 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for Breast Neoplasms
Sites in Palo Alto, Santa Clara +124 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
Sites in Palo Alto, Vallejo +84 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
Sites in Palo Alto, Fremont +170 more locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for Healthy
Sites in Palo Alto, Lancaster +116 more locations
Sponsor: Pfizer
Sex: All·Age: 1 Day - 49·Accepts healthy volunteers
Code: NCT07160244·Phase 3·Recruiting·Listed Sep 2025
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Palo Alto, Santa Clara +123 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for Breast Neoplasms
Drug: Pumitamig
Sites in Palo Alto, Sacramento +69 more locations
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT07173751·Phase 3·Recruiting·Listed Sep 2025
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Palo Alto, Walnut Creek +89 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
Sites in Palo Alto, Santa Barbara +42 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sites in Palo Alto, San Francisco +51 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136650·Phase 3·Recruiting·Listed Nov 2023
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for NonSegmental Vitiligo
Drug: Ruxolitinib
Sites in Palo Alto, Walnut Creek +67 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 2 - 11
Code: NCT06548360·Phase 3·Recruiting·Listed Aug 2024
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for Solid Tumors
Sites in Palo Alto, San Francisco +39 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for Breast Cancer
Sites in Palo Alto, Sunnyvale +59 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06790693·Phase 3·Recruiting·Listed Jan 2025
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for Parkinson's Disease
Drug: Prasinezumab
Sites in Palo Alto, Stanford +51 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 85
Code: NCT07174310·Phase 3·Recruiting·Listed Sep 2025
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
Sites in Palo Alto, Santa Clara +45 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06973187·Phase 3·Recruiting·Listed May 2025
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for Chronic Spontaneous Urticaria (CSU)
Drug: Remibrutinib
Sites in Palo Alto, Redwood City +127 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for PIK3CA Mutation
Sites in Palo Alto, Vallejo +50 more locations
Sponsor: Relay Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06982521·Phase 3·Recruiting·Listed May 2025
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for Diabetes Mellitus, Type 2
Sites in Palo Alto, Valencia +121 more locations
Sponsor: Cleerly, Inc.
Sex: All·Age: 55+·Accepts healthy volunteers
Code: NCT06112418·Recruiting·Listed Nov 2023
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for Prostate Cancer Metastatic
Sites in Palo Alto, Riverside +31 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136624·Phase 3·Recruiting·Listed Nov 2023
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for Oligometastatic Prostate Cancer (OMPC)
Sites in Palo Alto, San Francisco +35 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT05939414·Phase 3·Recruiting·Listed Jul 2023
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for Non-Small Cell Lung Cancer
Drug: Divarasib
Sites in Palo Alto, San Francisco +58 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Palo Alto, Redwood City +2386 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for Breast Cancer
Sites in Palo Alto, San Francisco +47 more locations
Sponsor: Greenwich LifeSciences, Inc.
Sex: All·Age: 18 - 100
Code: NCT05232916·Phase 3·Recruiting·Listed Feb 2022
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for RSV Infection
Sites in Palo Alto, Los Angeles +78 more locations
Sponsor: Pfizer
Sex: All·Age: 0+·Accepts healthy volunteers
Code: NCT06866405·Phase 3·Recruiting·Listed Mar 2025
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for Pancreatic Neuroendocrine Tumor (pNET)
Sites in Palo Alto, Vallejo +38 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06943755·Phase 2, Phase 3·Recruiting·Listed Apr 2025
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
for Focal Epilepsy
Drug: BHV-7000
Sites in Palo Alto, Los Angeles +43 more locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 18 - 75
Code: NCT06132893·Phase 2, Phase 3·Recruiting·Listed Nov 2023
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for Obstructive Hypertrophic Cardiomyopathy
Drug: Mavacamten
Sites in Palo Alto, San Francisco +46 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05489705·Recruiting·Listed Aug 2022
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
Sites in Palo Alto, Sacramento +43 more locations
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
Sites in Palo Alto, San Francisco +44 more locations
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
Sites in Palo Alto, Los Angeles +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for Prostate Cancer
Sites in Palo Alto, Santa Barbara +33 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06780670·Phase 2, Phase 3·Recruiting·Listed Jan 2025
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for Chronic Lymphocytic Leukemia
Drug: Sonrotoclax
Sites in Palo Alto, Orange +37 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06943872·Phase 3·Recruiting·Listed Apr 2025
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
for Head and Neck Squamous Cell Carcinoma
Sites in Palo Alto, Santa Rosa +29 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06163534·Recruiting·Listed Dec 2023
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for Prostate Cancer
Sites in Palo Alto, Santa Barbara +36 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06855277·Phase 3·Recruiting·Listed Mar 2025
Top Research Study Locations in Palo Alto
Researchers run research studies in Palo Alto, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Stanford University | Myelodysplastic Syndromes, Amblyopia, Healthy | 166 |
| Stanford Cancer Institute Palo Alto | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Recurrent Endometrial Carcinoma | 31 |
| Stanford University Medical Center | Cystic Fibrosis, Prostate Cancer, Acute Lymphoblastic Leukemia | 28 |
| VA Palo Alto Health Care System, Palo Alto, CA | Homelessness, Stress Disorders, Post-Traumatic, Substance Use Disorder | 28 |
| Lucile Packard Children's Hospital | Hematologic Diseases, Heart Failure, Pneumonia | 27 |
| Lucile Packard Children's Hospital Stanford University | Osteosarcoma, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 23 |
| VA Palo Alto Health Care System | Alcohol Use Disorder, Advanced Malignant Solid Neoplasm, Alcohol Abuse | 20 |
| Stanford University School of Medicine | Epilepsy, Health Behavior, Lifestyle Intervention | 19 |
| Stanford Cancer Institute | Chronic Lymphocytic Leukemia, Breast Cancer, Small Lymphocytic Lymphoma | 18 |
| Stanford Cancer Center | Leukemia, Myeloid, Acute, Advanced Breast Cancer, Advanced Solid Tumors | 18 |
| Lucile Packard Children's Hospital Stanford | Surgery, Acute Kidney Injury, Acute Kidney Injury Due to Sepsis | 17 |
| Palo Alto Medical Foundation Health Care | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma | 16 |
| Stanford | Epilepsy, Epilepsy (Treatment Refractory), AML (Acute Myelogenous Leukemia) | 11 |
| Stanford Neuroscience Health Center | Alzheimer's Disease, Amyloid, Becker Muscular Dystrophy | 10 |
| Stanford Hospital | Drug Liking, Angina Pectoris, Autoimmune | 7 |
| Byers Eye Institute | Glaucoma, Eye Disorders, Astigmatism | 6 |
| Byers Eye Institute at Stanford University | Glaucoma, Blindness, Eye Cancer | 6 |
| Stanford Health Care | Cholecystitis, Cholecystitis, Chronic, Chronic Calculous Cholecystitis | 6 |
| Stanford Medical Center | AML - Acute Myeloid Leukemia, Alzheimer Disease, Chronic Myeloid Leukemia | 6 |
| Stanford Medicine | B-cell Malignancy, Chronic Lymphocytic Leukemia, Diabetes Mellitus, Type 1 | 6 |
| Stanford University, School of Medicine | Liver Cancer, Adult, Lung Carcinoma, Lymphoma | 5 |
| Stanford Women's Cancer Center | Breast Cancer, Advanced Breast Cancer, Fallopian Tube Neoplasms | 5 |
| Lucille Packard Children's Hospital | Anesthesia, Local, Intubation Complication, Obstetric Pain | 4 |
| Stanford Hospital and Clinics | Implant Based Breast Reconstruction, Chronic Ischemic Left Ventricular Dysfunction, Lymphedema Arm | 4 |
| Lucile Packard Children's Hospital at Stanford | Cardiac MRI, Cell Free DNA, Congenital Heart Disease | 3 |
Active & Upcoming Studies in Palo Alto (2026)
Recruiting trials in Palo Alto grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (187 active studies)
- The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy · EARLY_Phase 1 · Stanford University
- End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases. · Stanford University
Neurology & pain (44 active studies)
- Suzetrigine in Tonsillectomy for Opioid-sparing Pain Management · Phase 4 · Stanford University
- Empowered Relief for Caregivers · Stanford University
Cardiovascular (36 active studies)
- The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome · VA Office of Research and Development
- Empowering Veterans in Research Effectively Using Virtual Engagement Tools · VA Office of Research and Development
Mental health & behavior (18 active studies)
- Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days · Phase 3 · VA Office of Research and Development
- Employing Peer Outreach and Whole Health in Recovery for Homeless-Experienced Veterans · VA Office of Research and Development
Eye & vision (15 active studies)
- Topical Insulin for Glaucoma (TING2) · Phase 1, Phase 2 · Stanford University
- Phase 1 Study of C.001 in Retinal Degeneration · Phase 1 · Cellio Therapeutics Inc
Diabetes & metabolic (14 active studies)
- Simplifying Diet Tracking in a Digital Weight Loss Intervention · Stanford University
- Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise · Stanford University
Pediatric (14 active studies)
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
- GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults · Phase 1 · Stanford University
Vaccines (7 active studies)
- Microbial and Cytokine Signatures in Long COVID Patients · Palo Alto Medical Foundation
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
HIV / STI (1 active study)
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions · Phase 2 · AusperBio Therapeutics Inc.
Common conditions studied in Palo Alto
- Cancer (8 active studies)
- Breast Cancer (7 active studies)
- Chronic Lymphocytic Leukemia (7 active studies)
- Epilepsy (7 active studies)
- Heart Failure (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
Leading research sponsors in Palo Alto
- Stanford University
- VA Office of Research and Development
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Palo Alto?
There are approximately 654 recruiting clinical trials in Palo Alto, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Palo Alto pay participants?
Most recruiting trials in Palo Alto compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Palo Alto?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Palo Alto?
The most common conditions under active study in Palo Alto include Cancer (8), Breast Cancer (7), Chronic Lymphocytic Leukemia (7), Epilepsy (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Palo Alto?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Palo Alto on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Palo Alto?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Palo Alto?
Recruiting research sites in Palo Alto include Stanford University, Stanford Cancer Institute Palo Alto, Stanford University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Palo Alto right now?
The largest active categories in Palo Alto are Cancer & tumors (187), Neurology & pain (44), Cardiovascular (36). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in California
Los Angeles, CA(1,993)San Francisco, CA(1,337)San Diego, CA(760)Sacramento, CA(583)Duarte, CA(546)La Jolla, CA(542)Orange, CA(517)Stanford, CA(424)Irvine, CA(388)Long Beach, CA(210)Walnut Creek, CA(186)Newport Beach, CA(183)Santa Monica, CA(178)Oakland, CA(171)Beverly Hills, CA(166)Torrance, CA(165)Loma Linda, CA(161)Anaheim, CA(124)Fresno, CA(104)Pasadena, CA(104)Santa Rosa, CA(104)Glendale, CA(98)Redwood City, CA(97)Fountain Valley, CA(94)Riverside, CA(91)Fullerton, CA(90)Lancaster, CA(89)Los Alamitos, CA(85)Fremont, CA(82)Huntington Beach, CA(77)San Jose, CA(75)Santa Barbara, CA(73)Roseville, CA(71)Vallejo, CA(65)Modesto, CA(64)Bakersfield, CA(61)Northridge, CA(60)Thousand Oaks, CA(60)Chula Vista, CA(57)Upland, CA(57)Berkeley, CA(56)Burbank, CA(54)Santa Clara, CA(49)Stockton, CA(49)Oceanside, CA(48)Pomona, CA(48)Santa Ana, CA(47)Garden Grove, CA(45)Bellflower, CA(44)San Leandro, CA(43)Santa Maria, CA(43)Downey, CA(42)Tarzana, CA(42)Oxnard, CA(41)San Luis Obispo, CA(41)Davis, CA(40)San Rafael, CA(40)Arroyo Grande, CA(37)Dublin, CA(37)La Mesa, CA(37)